Search Results - "Marroquin Belaunzaran, Osiris"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    Chronic delivery of antibody fragments using immunoisolated cell implants as a passive vaccination tool by Marroquin Belaunzaran, Osiris, Cordero, Maria Isabel, Setola, Veronica, Bianchi, Siro, Galli, Carmela, Bouche, Nicolas, Mlynarik, Vladimir, Gruetter, Rolf, Sandi, Carmen, Bensadoun, Jean-Charles, Molinari, Maurizio, Aebischer, Patrick

    Published in PloS one (20-04-2011)
    “…Monoclonal antibodies and antibody fragments are powerful biotherapeutics for various debilitating diseases. However, high production costs, functional…”
    Get full text
    Journal Article
  4. 4
  5. 5

    IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity by Rafiei, Anahita, Gualandi, Marco, Yang, Chia-Lung, Woods, Richard, Kumar, Anil, Brunner, Kathrin, Sigrist, John, Ebersbach, Hilmar, Coats, Steve, Renner, Christoph, Marroquin Belaunzaran, Osiris

    Published in Cancers (21-08-2024)
    “…HLA-B27 and HLA-B57 are associated with autoimmunity and long-term viral control and protection against HIV and HCV infection; however, their role in cancer…”
    Get full text
    Journal Article
  6. 6

    865 iosH2 exerts potent anti-tumor activity by blocking LILRB1/2 and KIR3DL1 receptor signaling by Belaunzaran, Osiris Marroquin, Rafiei, Anahita, Kumar, Anil, Gualandi, Marco, Westphal, Magdalena, Vogt, Lorenz, Smith, Sean, Curran, Michael, Renner, Christoph

    Published in Journal for immunotherapy of cancer (01-11-2021)
    “…BackgroundTo develop novel anti-cancer therapeutics we have used a reverse rational approach and searched for human HLA class I molecules known to induce…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    216 Anti-tumor activity of iosH2 by blocking LILRB2 receptor signalling by Osiris Marroquin Belaunzaran, Rafiei, Anahita, Kumar, Anil, Kolibaba, Julia, Vogt, Lorenz, Smith, Sean, Renner, Christoph

    Published in Journal for immunotherapy of cancer (01-11-2020)
    “…BackgroundThe human leukocyte immunoglobulin-like receptor family B (LILR B) acts as check point blockade of the innate immune system by inhibiting leukocyte…”
    Get full text
    Journal Article
  10. 10

    Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply by McHugh, Kirsty, Rysnik, Oliwia, Kollnberger, Simon, Shaw, Jacqueline, Utriainen, Lotta, Al-Mossawi, Mohammad Hussein, Payeli, Sravan, Belaunzaran, Osiris Marroquin, Milling, Simon, Renner, Christoph, Bowness, Paul

    Published in Annals of the rheumatic diseases (01-04-2014)
    “…Cellular expression of non-classical forms of human leukocyte antigen (HLA)-B27 (NC-B27) may be involved in spondyloarthritis (SpA) pathogenesis. We used a…”
    Get more information
    Journal Article
  11. 11

    HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats: e0130811 by Belaunzaran, Osiris Marroquin, Kleber, Sascha, Schauer, Stefan, Hausmann, Martin, Nicholls, Flora, Broek, Maries Vanden, Payeli, Sravan, Ciurea, Adrian, Milling, Simon, Stenner, Frank

    Published in PloS one (01-06-2015)
    “…Objectives HLA-B27 is a common genetic risk factor for the development of Spondyloarthritides (SpA). HLA-B27 can misfold to form cell-surface heavy chain…”
    Get full text
    Journal Article